LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 70.81 | 84.90 | 8080 | 9132 | 0.8848 | 0.9641 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 70.81 | 84.90 | 8818 | 9132 | 0.9656 | 0.9897 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 70.81 | 84.90 | 1024 | 9132 | 0.1121 | 0.4462 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 70.81 | 84.90 | 9734 | 9132 | 1.0659 | 1.0190 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 72.52 | 84.90 | 7882 | 9214 | 0.8554 | 0.9543 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 72.52 | 84.90 | 9009 | 9214 | 0.9777 | 0.9933 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 72.52 | 84.90 | 1104 | 9214 | 0.1198 | 0.4614 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 72.52 | 84.90 | 9958 | 9214 | 1.0807 | 1.0231 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 74.22 | 84.90 | 7368 | 9343 | 0.7886 | 0.9312 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 74.22 | 84.90 | 9178 | 9343 | 0.9823 | 0.9947 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 74.22 | 84.90 | 959 | 9343 | 0.1026 | 0.4297 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 74.22 | 84.90 | 10082 | 9343 | 1.0790 | 1.0226 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 75.93 | 84.90 | 7263 | 8970 | 0.8096 | 0.9382 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 75.93 | 84.90 | 9239 | 8970 | 1.0299 | 1.0088 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 75.93 | 84.90 | 1117 | 8970 | 0.1245 | 0.4671 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 75.93 | 84.90 | 10330 | 8970 | 1.1515 | 1.0424 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 77.64 | 84.90 | 6989 | 9245 | 0.7559 | 0.9190 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 77.64 | 84.90 | 9373 | 9245 | 1.0138 | 1.0040 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 77.64 | 84.90 | 1038 | 9245 | 0.1123 | 0.4477 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 77.64 | 84.90 | 10528 | 9245 | 1.1387 | 1.0388 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 79.34 | 84.90 | 6739 | 9051 | 0.7445 | 0.9143 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 79.34 | 84.90 | 9409 | 9051 | 1.0395 | 1.0115 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 79.34 | 84.90 | 988 | 9051 | 0.1092 | 0.4396 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 79.34 | 84.90 | 10649 | 9051 | 1.1765 | 1.0488 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 81.05 | 84.90 | 6257 | 8863 | 0.7059 | 0.8988 | MN20160318_Q02 | H11 |